2019
DOI: 10.1007/s00246-019-02108-0
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Long-Term Support with Berlin Heart EXCOR® in Pediatric Patients with Severe Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…The severely decompensated infant was successfully switched from ECMO to a durable ventricular assist device and underwent transplantation safely. Frequent cerebrovascular complications have been reported with the Berlin Heart EXCOR (Berlin Heart GmbH) [10]. In this case, the patient received warfarin and dual antiplatelet therapy, and was free of any neurologic events.…”
Section: Kjtcvsmentioning
confidence: 88%
“…The severely decompensated infant was successfully switched from ECMO to a durable ventricular assist device and underwent transplantation safely. Frequent cerebrovascular complications have been reported with the Berlin Heart EXCOR (Berlin Heart GmbH) [10]. In this case, the patient received warfarin and dual antiplatelet therapy, and was free of any neurologic events.…”
Section: Kjtcvsmentioning
confidence: 88%
“…b Computed tomography confirmed diaphragmatic hernia small patients [5] and may function as a bridge to transplantation or recovery [6]. The waiting period for heart transplantation is longer in Japan than the global average because of the severe shortage of organ donations for children, so the duration of LVAD implantation may be unavoidably long [1,7].…”
Section: Discussionmentioning
confidence: 99%
“…Left ventricular assist devices (LVADs) have become popular in children with the advent of the Berlin Heart EXCOR® (BHE) VAD (Berlin Heart, Inc., The Woodlands, TX, USA). The BHE VAD provides long-term circulatory support for pediatric patients with severe heart failure, not only functioning as a bridge to transplantation but also facilitating the successful weaning off of a VAD [ 1 ]. Although advances in VAD technology and clinical management have resulted in improved outcomes of pediatric heart failure, VADs are associated with potential risks of neurologic, hematologic, gastrointestinal, and immunologic complications [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…There were 41 857 articles identified with the search strategy, of which 14 3,5,9,[22][23][24][25][26][27][28][29][30][31][32] were kept in the final review (Figure 1). Within these studies, with data ranging from 1990 to 2020, 58 hospitals in North America, Europe, Australia, and Asia supported 984 children with BHE (Table 1).…”
Section: Overall Study Populationmentioning
confidence: 99%